Meeder Asset Management Inc. Has $67,000 Stock Position in The Procter & Gamble Company (NYSE:PG)

Meeder Asset Management Inc. lowered its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 89.6% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 406 shares of the company’s stock after selling 3,485 shares during the quarter. Meeder Asset Management Inc.’s holdings in Procter & Gamble were worth $67,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Gilbert & Cook Inc. grew its position in shares of Procter & Gamble by 7.7% in the fourth quarter. Gilbert & Cook Inc. now owns 17,215 shares of the company’s stock valued at $2,523,000 after purchasing an additional 1,237 shares during the last quarter. Gryphon Financial Partners LLC grew its position in shares of Procter & Gamble by 8.2% in the fourth quarter. Gryphon Financial Partners LLC now owns 84,360 shares of the company’s stock valued at $12,341,000 after purchasing an additional 6,390 shares during the last quarter. Fiera Capital Corp grew its position in shares of Procter & Gamble by 4.9% in the fourth quarter. Fiera Capital Corp now owns 1,453 shares of the company’s stock valued at $213,000 after purchasing an additional 68 shares during the last quarter. Cowen AND Company LLC acquired a new position in shares of Procter & Gamble in the fourth quarter valued at approximately $440,000. Finally, Mizuho Markets Americas LLC grew its position in shares of Procter & Gamble by 36.6% in the fourth quarter. Mizuho Markets Americas LLC now owns 30,171 shares of the company’s stock valued at $4,421,000 after purchasing an additional 8,081 shares during the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the transaction, the insider now owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction dated Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the transaction, the chief financial officer now directly owns 37,208 shares in the company, valued at approximately $6,325,360. The disclosure for this sale can be found here. In the last ninety days, insiders sold 375,553 shares of company stock worth $63,829,141. Company insiders own 0.17% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on PG shares. Dbs Bank cut Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. JPMorgan Chase & Co. cut their price target on Procter & Gamble from $181.00 to $179.00 and set an “overweight” rating for the company in a research note on Wednesday, July 31st. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, August 23rd. StockNews.com cut Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Finally, Evercore ISI upped their target price on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research note on Thursday, July 18th. Seven research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $175.79.

Read Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Performance

Shares of Procter & Gamble stock opened at $174.08 on Friday. The company has a current ratio of 0.73, a quick ratio of 0.53 and a debt-to-equity ratio of 0.51. The business has a 50-day moving average price of $169.38 and a two-hundred day moving average price of $165.21. The Procter & Gamble Company has a 1-year low of $141.45 and a 1-year high of $177.94. The company has a market cap of $410.85 billion, a P/E ratio of 28.44, a PEG ratio of 3.77 and a beta of 0.41.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.03. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. The firm had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. During the same period last year, the business posted $1.37 EPS. The business’s revenue was down .1% compared to the same quarter last year. As a group, analysts anticipate that The Procter & Gamble Company will post 6.97 EPS for the current year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Shareholders of record on Friday, July 19th were issued a dividend of $1.0065 per share. The ex-dividend date of this dividend was Friday, July 19th. This represents a $4.03 dividend on an annualized basis and a yield of 2.31%. Procter & Gamble’s payout ratio is currently 65.85%.

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.